Skip to content

Canceled by the investigator. Effect of low-dose esketamine in gynecological surgery on postoperative cognitive impairment

Effect of low-dose esketamine in gynecological surgery on postoperative cognitive impairment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030808
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-04-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive dysfunction in gynecological patients

Interventions

Saline group:5ml of 0.9% physiological saline solution was injected. Esketamine was not added to the postoperative analgesic pump, and an equal amount of normal saline was used instead. No difference
Analgesic pump administration group:Add 40mg esketamine to analgesia pump after anesthesia
Single intravenous combined analgesia pump:During anesthesia, esketamine was injected intravenously at 0.25 mg / kg, and dissolved in 5 ml of a colorless transparent solution using 0.9% physiological

Sponsors

Department of Anesthesiology, Shengjing Hospital, China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged over 40 years who were selected for gynecological surgery at Shengjing Hospital were selected. The inclusion criteria were: patients who underwent laparotomy in Shengjing Hospital: 1. Patients aged >= 40 years; 2. Surgery time >= 2h; 3. Good coordination, able to understand and cooperate with the completed measurement scale; 4. ASA classification Grade I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with mental illness such as depression; 2. Refusal to use postoperative analgesia pumps; 3. Patients with severe obstetric complications or severe underlying diseases such as hypertension, hyperthyroidism, epilepsy, increased intracranial pressure or cranial Ketamine contraindications such as internal space-occupying lesions and a history of cardiovascular and cerebrovascular accidents; 4. History of drug and alcohol addiction.

Design outcomes

Primary

MeasureTime frame
Mini mental status examination (MMSE) assessment;

Secondary

MeasureTime frame
preoperative data;intraoperative data;Postoperative indicators;

Countries

China

Contacts

Public ContactPing Zhao

Department of Anesthesiology, Shengjing Hospital, China Medical University

zhaop@sj-hospital.org+86 18940258971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026